tim@emorningcoffee.com
Week ended Sept 13, 2024: it was an "everything up" week
It was one of those weeks that if you didn't chalk up portfolio gains, it would be difficult to figure out why. Bonds and stocks rallied.
top of page
Home: Welcome
My view on what's going on in the financial markets and the global economy, and a few other things that might interest me from time to time.
Search
tim@emorningcoffee.com
- 7 days ago
- 6 min
Week ended Sept 6, 2024: sentiment deteriorates
US Labor Day holiday marked the unofficial end of summer, and also a demarcation for risk sentiment. Bonds rallied and stocks got hammered.
290
tim@emorningcoffee.com
- Jul 24
- 8 min
Portfolio update: 1H2024
This is an update of my personal portfolio performance in 2Q2024 and 1H2024, good on the surface but worse than the indices would suggest.
520
tim@emorningcoffee.com
- Jun 25
- 6 min
US deficits / debt soar; should you care?
US deficits are soaring, along with US debt to finance the "exceptional growth" of the US. Can this continue?
500
tim@emorningcoffee.com
- Jun 12
- 7 min
Midweek update: Apple, CPI/FOMC, GME
We have some US data coming that might matter today (CPI), but the FOMC will sit tight (also today). Discusses Apple's run and GameStop.
220
tim@emorningcoffee.com
- May 2
- 14 min
Is fine wine a good investment?
The 2024 en primeur campaign for Bordeaux is just starting. But is fine wine really a good investment? I don't think so anymore.
1564
tim@emorningcoffee.com
- Apr 10
- 8 min
Portfolio update: 1Q2024
This is an update about my personal portfolio during and at the end of 1Q2024. It also discusses performance which I consider disappointing.
710
tim@emorningcoffee.com
- Mar 18
- 8 min
Anti-obesity medications: part 3, valuations of LLY and NVO
This is the 3rd and final article focused on anti-obesity drugs. It looks at valuations of shares of the two giants in this biz, LLY & NVO.
420
tim@emorningcoffee.com
- Mar 14
- 7 min
Anti-obesity medications part 2: the duopoly of Eli Lilly and Novo Nordisk
Eli Lilly (LLY) and Novo Nordisk (NVO) have been large players for decades in the market for diabetes medications and are currently...
380
tim@emorningcoffee.com
- Mar 12
- 7 min
Anti-obesity medications part 1: the market for anti-obesity drugs
This article is being published in instalments, of which this is the first, for context. INTRODUCTION Two macrotrends have been drivers...
690
tim@emorningcoffee.com
- Mar 5
- 4 min
Revisiting gold as an asset class
This is a guest post about gold, penned by online investment firm BullionVault. Gold has just pierced $2,100/oz, reaching a record high.
840
tim@emorningcoffee.com
- Feb 27
- 9 min
Berkshire Hathaway: 2023 results and the path forward
Berkshire Hathaway released its FY earnings on Sat. As always, there are plenty of juicy nuggets to digest.
1460
tim@emorningcoffee.com
- Feb 20
- 5 min
Revisiting semi-conductors
This article takes a quick look at the semi-conductor value-chain, including chip designers, fabricators and chip machinery makers.
690
tim@emorningcoffee.com
- Feb 14
- 7 min
Enhancing shareholder value
Looks at ways companies can maximise shareholder value (aside from uttering the words “AI”) including dividends, stock buybacks & layoffs
530
tim@emorningcoffee.com
- Jan 25
- 6 min
Portfolio update Dec 31, 2023 (4Q23 and FY 2023)
This article provides a 4Q23 update on my personal portfolio. I was conservatively positioned going into an unexpectedly strong quarter.
830
tim@emorningcoffee.com
- Jan 2
- 31 min
Some investment "thoughts" to start off the new year
2023 was an amazing year for nearly all traditional asset classes around the world. Can this carry-on? This article covers my thoughts.
1920
tim@emorningcoffee.com
- Dec 7, 2023
- 8 min
Spending your retirement savings
I wrote about portfolio allocation pre-retirement a few weeks ago. This article is about “sizing” your drawdowns after you retire.
2700
tim@emorningcoffee.com
- Nov 30, 2023
- 7 min
Personal portfolio allocation
This article is about the allocation of yours savings across different asset classes to maximise returns given your risk profile
1470
Home: Blog2
bottom of page